A Novel DNA Vaccine Technology Conveying Protection against a Lethal Herpes Simplex Viral Challenge in Mice

• Julie L. Dutton,

  Affiliation Coridon Pty Ltd, Brisbane, Queensland, Australia

  ⨯
• Bo Li,

  Affiliation Coridon Pty Ltd, Brisbane, Queensland, Australia

  ⨯
• Wai-Ping Woo,

  Affiliation Coridon Pty Ltd, Brisbane, Queensland, Australia

  ⨯
• Joshua O. Marshak,

  Affiliation Department of Medicine, University of Washington, Seattle, Washington, United States of America

  ⨯
• Yan Xu,

  Affiliation Coridon Pty Ltd, Brisbane, Queensland, Australia

  ⨯
• Meei-li Huang,

  Affiliations Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America, Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Institute, Seattle, Washington, United States of America

  ⨯
• Lichun Dong,

  Affiliation Department of Medicine, University of Washington, Seattle, Washington, United States of America

  ⨯
• Ian H. Frazer,

  Affiliations Coridon Pty Ltd, Brisbane, Queensland, Australia, Diamantina Institute, University of Queensland, Brisbane, Queensland, Australia

  ⨯
• David M. Koelle

  * E-mail: viralimm@u.washington.edu

  Affiliations Department of Medicine, University of Washington, Seattle, Washington, United States of America, Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America, Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Institute, Seattle, Washington, United States of America, Department of Global Health, University of Washington, Seattle, Washington, United States of America, Benaroya Research Institute, Seattle, Washington, United States of America

  ⨯